American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: Venous Thromboembolism in the Context of Pregnancy

Overview

Journal Blood Adv

Specialty Hematology

Date 2018 Nov 29

PMID 30482767

Citations 146

Authors

Shannon M Bates

Anita Rajasekhar

Saskia Middeldorp

Claire McLintock

Marc A Rodger

Andra H James

Sara R Vazquez

Ian A Greer

John J Riva

Meha Bhatt

Nicole Schwab

Danielle Barrett

Andrea LaHaye

Bram Rochwerg

Affiliations

Soon will be listed here.

Abstract

Background: Venous thromboembolism (VTE) complicates ∼1.2 of every 1000 deliveries. Despite these low absolute risks, pregnancy-associated VTE is a leading cause of maternal morbidity and mortality.

Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians and others in decisions about the prevention and management of pregnancy-associated VTE.

Methods: ASH formed a multidisciplinary guideline panel balanced to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process, including updating or performing systematic evidence reviews. The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess evidence and make recommendations.

Results: The panel agreed on 31 recommendations related to the treatment of VTE and superficial vein thrombosis, diagnosis of VTE, and thrombosis prophylaxis.

Conclusions: There was a strong recommendation for low-molecular-weight heparin (LWMH) over unfractionated heparin for acute VTE. Most recommendations were conditional, including those for either twice-per-day or once-per-day LMWH dosing for the treatment of acute VTE and initial outpatient therapy over hospital admission with low-risk acute VTE, as well as against routine anti-factor Xa (FXa) monitoring to guide dosing with LMWH for VTE treatment. There was a strong recommendation (low certainty in evidence) for antepartum anticoagulant prophylaxis with a history of unprovoked or hormonally associated VTE and a conditional recommendation against antepartum anticoagulant prophylaxis with prior VTE associated with a resolved nonhormonal provoking risk factor.

Citing Articles

Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis-Where Do We Stand?.

Vojjala N, Peshin S, Kattamuri L, Iqbal R, Dharia A, Jayakumar J Biomedicines. 2025; 13(1).

PMID: 39857772 PMC: 11759824. DOI: 10.3390/biomedicines13010189.

Hematologic Complications of Pregnancy.

Patel P, Patel N, Hedges M, Benson A, Tomer A, Lo J Eur J Haematol. 2025; 114(4):596-614.

PMID: 39790057 PMC: 11882378. DOI: 10.1111/ejh.14372.

Role of Antiplatelets and Anticoagulation Therapies in Pregnancy.

Zachariah K, Yuan S, DeSancho M, Landres I, Singh H J Clin Med. 2025; 13(24.

PMID: 39768679 PMC: 11678094. DOI: 10.3390/jcm13247757.

A 27-Year-Old Japanese Woman Presenting with Left Chest Wall Pain Due to Palpable and Visible Sclerosing Superficial Thrombophlebitis (Mondor's Disease).

Takahashi Y, Deshpande G, Mine Y, Saita M, Naito T Am J Case Rep. 2025; 26():e945901.

PMID: 39763158 PMC: 11725653. DOI: 10.12659/AJCR.945901.

Scheres L, Middeldorp S Hematology Am Soc Hematol Educ Program. 2024; 2024(1):664-671.

PMID: 39644057 PMC: 11665521. DOI: 10.1182/hematology.2024000593.

References

Olthof E, De Vries T . [Breast feeding and oral anticoagulants]. Tijdschr Kindergeneeskd. 1993; 61(5):175-7. View

Greinacher A, Eckhardt T, Mussmann J, MUELLER-ECKHARDT C . Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172). Thromb Res. 1993; 71(2):123-6. DOI: 10.1016/0049-3848(93)90178-q. View

Virkus R, Lokkegaard E, Lidegaard O, Langhoff-Roos J, Nielsen A, Rothman K . Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort. PLoS One. 2014; 9(5):e96495. PMC: 4008580. DOI: 10.1371/journal.pone.0096495. View

Jensen T, Gerds T, Gron R, Bretler D, Schmiegelow M, Andersson C . Risk factors for venous thromboembolism during pregnancy. Pharmacoepidemiol Drug Saf. 2013; 22(12):1283-91. DOI: 10.1002/pds.3536. View

Galambosi P, Hiilesmaa V, Ulander V, Laitinen L, Tiitinen A, Kaaja R . Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density. Thromb Res. 2016; 143:122-6. DOI: 10.1016/j.thromres.2016.05.016. View

McDonnell B, Glennon K, McTiernan A, OConnor H, Kirkham C, Kevane B . Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism. J Thromb Thrombolysis. 2016; 43(1):105-111. DOI: 10.1007/s11239-016-1409-5. View

Chan W, Chunilal S, Lee A, Crowther M, Rodger M, Ginsberg J . A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy. Ann Intern Med. 2007; 147(3):165-70. DOI: 10.7326/0003-4819-147-3-200708070-00005. View

Schunemann H, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R . Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2013; 186(3):E123-42. PMC: 3928232. DOI: 10.1503/cmaj.131237. View

Schunemann H, Al-Ansary L, Forland F, Kersten S, Komulainen J, Kopp I . Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines. Ann Intern Med. 2015; 163(7):548-53. DOI: 10.7326/M14-1885. View

10.

Salvatori M, Treglia G, Mores N . Further considerations on adverse reactions to radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 2012; 39(8):1360-2. DOI: 10.1007/s00259-012-2120-1. View

11.

Danilenko-Dixon D, Heit J, Silverstein M, Yawn B, Petterson T, Lohse C . Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol. 2001; 184(2):104-10. DOI: 10.1067/mob.2001.107919. View

12.

Dahlman T . Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 1993; 168(4):1265-70. DOI: 10.1016/0002-9378(93)90378-v. View

13.

Haapsamo M, Martikainen H, Tinkanen H, Heinonen S, Nuojua-Huttunen S, Rasanen J . Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. Hum Reprod. 2010; 25(12):2972-7. DOI: 10.1093/humrep/deq286. View

14.

Peeters L, Hobbelen P, Verkeste C, Vogel G, Hasenack H, Meuleman D . Placental transfer of Org 10172, a low-molecular weight heparinoid, in the awake late-pregnant guinea pig. Thromb Res. 1986; 44(3):277-83. DOI: 10.1016/0049-3848(86)90002-2. View

15.

Lindhoff-Last E, Bauersachs R . Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation. Semin Thromb Hemost. 2002; 28(5):439-46. DOI: 10.1055/s-2002-35284. View

16.

Bashir R, Zack C, Zhao H, Comerota A, Bove A . Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis. JAMA Intern Med. 2014; 174(9):1494-501. DOI: 10.1001/jamainternmed.2014.3415. View

17.

Serour G, Aboulghar M, Mansour R, Sattar M, Amin Y, Aboulghar H . Complications of medically assisted conception in 3,500 cycles. Fertil Steril. 1998; 70(4):638-42. DOI: 10.1016/s0015-0282(98)00250-7. View

18.

Ntusi N, Samuels P, Moosa S, Mocumbi A . Diagnosing cardiac disease during pregnancy: imaging modalities. Cardiovasc J Afr. 2016; 27(2):95-103. PMC: 4928175. DOI: 10.5830/CVJA-2016-022. View

19.

Le Gal G, Kercret G, Ben Yahmed K, Bressollette L, Robert-Ebadi H, Riberdy L . Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study. BMJ. 2012; 344:e2635. PMC: 3339806. DOI: 10.1136/bmj.e2635. View

20.

Tremblay E, Therasse E, Thomassin-Naggara I, Trop I . Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics. 2012; 32(3):897-911. DOI: 10.1148/rg.323115120. View